CROUSE WILLIAM W 4
4 · Targanta Therapeutics Corp. · Filed Feb 27, 2009
Insider Transaction Report
Form 4
CROUSE WILLIAM W
Director
Transactions
- Disposition from Tender
Common Stock
2009-02-25−58,539→ 0 total
Footnotes (1)
- [F1]The shares were tendered in a tender offer by Boxford Subsidiary Corporation for consideration of (1) $2.00 per common share in cash, plus (2) the contractual right to receive up to an additional $4.55 per common share in contingent cash payments if specified regulatory and commercial milestones are achieved within agreed upon time periods.